As Senior Director, Head of Commercial Europe, you will define and lead Taiho Oncology Europe's commercial strategy and execution across European markets. You will be accountable for European commercial planning and forecasting, launch execution, commercial performance, distributor and commercialization-partner governance.
The role combines strategic leadership with hands-on execution. Working closely with Market Access, Medical Affairs and other cross-functional leaders, as well as global colleagues in Japan and the US, you will translate strategy and market insight into clear priorities, disciplined execution and measurable commercial results.
Job requirements:
- Bachelor’s degree in business, life sciences, marketing or a related discipline; an advanced degree is advantageous.
- At least 10 years of progressive commercial experience in the pharmaceutical or biotechnology industry, including significant European multi-country responsibility and leadership experience.
- Demonstrated success leading commercial planning and product launches across multiple European markets; oncology, specialty or hospital pharmaceutical experience strongly preferred.
- Experience leading and developing commercial teams in a lean, entrepreneurial or evolving organization.
- Demonstrated experience in commercial forecasting, performance analytics, business planning, budget management and resource allocation.
- Experience managing distributors, commercialization partners or strategic alliances across European markets.
- Experience operating effectively in an international matrix and aligning European plans with global stakeholders, including Japan and the US.
- Strong working knowledge of European pharmaceutical commercialization, including relevant promotional, regulatory, market-access and compliance considerations.
- Strategic and analytical thinker who converts market insights and data into clear commercial decisions and measurable execution.
- Strong launch, forecasting and performance-management discipline, including the ability to challenge assumptions, identify risks and lead corrective action.
- Proven people leadership, coaching, organizational design and capability-building skills.
- Strong cross-functional leadership and the ability to build alignment and deliver results across functions, countries and global stakeholders.
- Skilled in distributor and partner governance, executive business reviews, negotiation and performance management.
- High standards of integrity and sound judgment in compliant customer engagement and commercial decision-making.
- Confident executive communicator, able to present clear recommendations, risks and trade-offs to European and global senior stakeholders.
- Fluent English; proficiency in an additional European language is advantageous.
- Entrepreneurial, hands-on and resilient; effective in a lean, fast-moving and internationally diverse organization.
Job responsibilities:
Commercial Strategy and Performance
- Define and execute the European commercial strategy, annual commercial plans and country or partner-market priorities in alignment with Taiho Oncology Europe and global objectives.
- Translate customer, market and competitive insights into clear choices on market prioritization, positioning, resource allocation, account strategy and execution.
- Be accountable for approved European commercial performance objectives. Establish and monitor relevant KPIs, including sales and revenue, market uptake, market share, launch progress, forecast accuracy, customer engagement and partner performance, and lead timely corrective or acceleration actions.
- Own the approved European commercial operating budget, monitor expenditure and commercial returns, and recommend the effective allocation of commercial resources in partnership with Finance.
Forecasting and Business Planning
- Own the European commercial forecast and its underlying assumptions, scenarios, risks and opportunities, including regular updates and variance explanations, in collaboration with Finance, Supply Chain, relevant European teams and partners, and global counterparts.
- Develop and regularly review European sales and commercial plans with counterparts in Japan and the US, ensuring alignment with global priorities while maintaining accountability for the quality, transparency and timely communication of the European commercial view.
Launch and Commercial Execution
- Lead European commercial launch readiness and execution, defining commercial milestones, KPIs, dependencies, risks, mitigation actions and post-launch optimization plans.
- Coordinate cross-functional launch execution with Market Access, Medical Affairs, Regulatory Affairs, Supply Chain, Finance, Legal and Compliance while respecting each function’s independent accountability and decision rights.
- Own commercial and promotional strategy and execution. Ensure customer-facing activities and materials are developed, reviewed, approved and implemented in accordance with applicable laws, industry codes, local requirements and company policies, with appropriate input and governance from Medical Affairs, Regulatory Affairs, Legal and Compliance.
- Take ownership of commercial decisions and outcomes within delegated authority; identify issues early, communicate risks transparently and lead timely corrective action.
People and Organizational Leadership
- Lead external commercial resources and service providers where relevant, setting clear expectations and holding them accountable for quality, compliance and results.
- Lead by example and foster a collaborative culture based on People, Accountability, Collaboration and Trust across the commercial team, the wider organization and external partners.
Portfolio, Global Alignment and External Representation
- Represent the European commercial perspective in relevant regional and global governance forums, ensuring that European market, customer and competitive insights inform global planning and decisions.
- Represent Taiho Oncology Europe at appropriate industry events and external forums.
Travel Requirements:
Regular travel across Europe and occasional travel to Japan, the US or other global locations; expected travel up to approximately 25%.